Online citations, reference lists, and bibliographies.
← Back to Search

Detection And Identification Of Peroxiredoxin 3 As A Biomarker In Hepatocellular Carcinoma By A Proteomic Approach.

Bingbing Qiao, Jiajia Wang, J. Xie, Ying Niu, Shaojun Ye, Q. Wan, Q. Ye
Published 2012 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide with poor prognosis due to resistance to conventional chemotherapy and limited efficacy of radiotherapy. Thus, alternative therapeutic strategies need to be established. In order to search for a useful biomarker to improve its efficacy, we conducted a two-dimensional gel electrophoresis and MALDI-TOF MS-based comparative proteomic analysis to profile the differentially expressed proteins between HCC tumor tissues with histological evidence and the adjacent non-tumor tissues. Twenty-two out of 43 dysregulated proteins were identified, including 15 upregulated proteins, and 7 downregulated proteins (over 2-fold, P<0.01). The expression of peroxiredoxin 3 (PRDX3) at the mRNA and protein levels was confirmed by RT-PCR and western blotting in HCC cell lines, and HCC samples, and further analysed by immunohistochemistry in HCC samples of different clinical pathological stages. The results indicated that overexpression of PRDX3 was associated with 94.9% HCC, and correlated with poor differentiation (P<0.05), which suggest that PRDX3 has substantial clinical impact on the progression of hepatocarcinoma, and may be a potential therapeutic target for HCC.
This paper references
Role of superoxide dismutase in cancer: a review.
L. Oberley (1979)
Overexpression of peroxiredoxin in human breast cancer.
D. Y. Noh (2001)
10.1074/JBC.M106585200
Proteomics Analysis of Cellular Response to Oxidative Stress
T. Rabilloud (2002)
10.1073/pnas.102523299
The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation
D. Wonsey (2002)
10.1093/JEXBOT/53.372.1321
The function of the chloroplast 2-cysteine peroxiredoxin in peroxide detoxification and its regulation.
K. Dietz (2002)
10.1002/path.1042
Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma
V. Kinnula (2002)
Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas.
J. H. Choi (2002)
10.1148/RADIOL.2241011262
Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.
C. Cammà (2002)
10.1200/JCO.2003.11.137
The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time.
H. Yoo (2003)
10.1038/nrd1130
Clinical biomarkers in drug discovery and development
R. Frank (2003)
Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium.
Y. J. Hu (2003)
10.1023/B:CANC.0000031769.14728.bc
Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: A unifying concept in stress response biology
D. Spitz (2004)
10.1074/JBC.M407707200
Peroxiredoxin III, a Mitochondrion-specific Peroxidase, Regulates Apoptotic Signaling by Mitochondria*
T. Chang (2004)
10.1055/S-2005-871198
Resection and liver transplantation for hepatocellular carcinoma.
J. Llovet (2005)
10.1038/sj.onc.1209550
New therapies for hepatocellular carcinoma
M. A. Avila (2006)
10.1038/sj.onc.1209373
Glutathione S-transferase polymorphisms: cancer incidence and therapy
C. McIlwain (2006)
10.1158/0008-5472.CAN-05-1357
Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1alpha in non-small cell lung cancer.
I. Csiki (2006)
10.1089/ARS.2007.9.49
Mechanisms of cell death in oxidative stress.
S. Ryter (2007)
10.3892/IJO.30.6.1545
Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs.
S. Chuthapisith (2007)
10.1016/j.ejso.2007.07.079
Proteomic profiling in defining chemoresistant breast cancer cells
S. Chuthapisith (2007)
10.1074/mcp.M700544-MCP200
Proteomics Identification of Cyclophilin A as a Potential Prognostic Factor and Therapeutic Target in Endometrial Carcinoma*
Z. Li (2008)
10.1016/j.canlet.2008.10.019
Proteomic identification of tumor-associated protein in ovarian serous cystadenocarinoma.
Xiu-qin Li (2009)
10.1038/nrd2803
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
D. Trachootham (2009)
10.1016/j.canlet.2009.01.034
Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
Fei-xiang Wu (2009)
10.3892/OR_00000366
Expression of human peroxiredoxin isoforms in response to cervical carcinogenesis.
Kiyoon Kim (2009)
10.1007/s00535-009-0160-5
The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma
S. Kanmura (2010)
10.1016/j.febslet.2010.06.002
The role of enoyl‐CoA hydratase short chain 1 and peroxiredoxin 3 in PP2‐induced apoptosis in human breast cancer MCF‐7 cells
X. Liu (2010)
10.14670/HH-25.1297
Peroxiredoxins in colorectal neoplasms.
X. Wu (2010)
10.1002/pmic.200900685
Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum‐resistant sublines
Zhiqin Dai (2011)
10.3892/OR_00000992
Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population.
I. Hlavatá (2010)
The role of enoylCoA hydratase short chain 1 and peroxiredoxin 3 in PP 2induced apoptosis in human breast cancer MCF7 cells
K Kim (2010)
10.1002/pros.21292
Differential expression of peroxiredoxins in prostate cancer: Consistent upregulation of PRDX3 and PRDX4
Anamika Basu (2011)
10.1186/1479-5876-9-171
Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview
M. Marra (2011)
10.1007/s00535-011-0392-z
Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma
Masayasu Jo (2011)
10.3390/ijms12107163
Mitochondrial Peroxiredoxin III is a Potential Target for Cancer Therapy
I. Song (2011)
: consistent upregulation of PRDX 3 and PRDX 4
X Liu (2011)



This paper is referenced by
10.3389/fimmu.2021.652782
Peroxiredoxin 3 Inhibits Acetaminophen-Induced Liver Pyroptosis Through the Regulation of Mitochondrial ROS
Yue Wang (2021)
10.1016/j.gpb.2020.09.005
Quantitative Secretome Analysis Reveals Clinical Values of Carbonic Anhydrase II in Hepatocellular Carcinoma
Xiaohua Xing (2021)
10.1101/2020.01.15.905687
Quantitative Analysis of Tissue Secretome Reveals the Diagnostic and Prognostic Value of Carbonic Anhydrase II in Hepatocellular Carcinoma
Xiaohua Xing (2020)
10.3390/biom10010135
Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer
R. Avolio (2020)
10.1007/978-3-030-21540-8_5
Analysis of Hepatocellular Carcinoma Tissue for Biomarker Discovery
Connor A. West (2019)
10.3390/antiox8010011
Peroxiredoxins in Cancer and Response to Radiation Therapies
T. Forshaw (2019)
10.1016/j.coph.2018.04.002
The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome
Alyson P Black (2018)
10.1089/ars.2017.7422
Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer.
M. Hampton (2017)
10.4254/wjh.v9.i1.1
Disease monitoring of hepatocellular carcinoma through metabolomics
A. I. Fitian (2017)
10.3390/ijms18102119
Transforming Growth Factor-β Drives the Transendothelial Migration of Hepatocellular Carcinoma Cells
Petra Koudelková (2017)
10.1177/1535370216669834
Epigenetic regulation of peroxiredoxins: Implications in the pathogenesis of cancer
Suet-Hui Ow (2017)
10.1016/j.pharmthera.2016.03.018
Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases
M. H. Park (2016)
10.1016/j.jprot.2016.03.050
The application of proteomics in different aspects of hepatocellular carcinoma research.
Xiaohua Xing (2016)
10.3748/wjg.v22.i37.8271
Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma
S. Van Hees (2016)
10.1002/mc.22371
The phospholipase A2 activity of peroxiredoxin 6 promotes cancer cell death induced by tumor necrosis factor alpha in hepatocellular carcinoma
Xiao Xu (2016)
10.1021/acs.jproteome.5b01125
Silencing PRDX3 Inhibits Growth and Promotes Invasion and Extracellular Matrix Degradation in Hepatocellular Carcinoma Cells.
Zhilei Liu (2016)
10.3892/or.2016.4842
Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review)
Patrick Reichl (2016)
10.1016/bs.acr.2014.11.005
Glycosylation and liver cancer.
A. Mehta (2015)
10.7314/APJCP.2015.16.4.1657
Plasma nuclear factor kappa B and serum peroxiredoxin 3 in early diagnosis of hepatocellular carcinoma.
S. Ismail (2015)
10.1007/s00432-015-1916-3
The functional role of peroxiredoxin 3 in reactive oxygen species, apoptosis, and chemoresistance of cancer cells
Lianqin Li (2015)
10.3390/biom5042554
Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry
T. Powers (2015)
10.3892/ijmm.2014.1806
Brain death induces the alteration of liver protein expression profiles in rabbits.
B. Du (2014)
10.7314/APJCP.2014.15.7.2979
Serum peroxiredoxin3 is a useful biomarker for early diagnosis and assessemnt of prognosis of hepatocellular carcinoma in Chinese patients.
L. Shi (2014)
10.14218/JCTH.2013.00022
Proteome Analyses of Hepatocellular Carcinoma
D. A. Megger (2014)
10.3892/mmr.2013.1370
siRNA targeting of PRDX3 enhances cisplatin‑induced apoptosis in ovarian cancer cells through the suppression of the NF‑κB signaling pathway.
J. Duan (2013)
10.18632/ONCOTARGET.1658
Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers
B. Rotblat (2013)
10.1007/s12032-013-0786-2
Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma
Qi-kai Sun (2013)
10.1002/elps.201300326
Myofibroblasts are important contributors to human hepatocellular carcinoma: Evidence for tumor promotion by proteome profiling
Astrid Slany (2013)
Protein profiling for hepatocellular carcinoma biomarker discovery in West African subjects
H. Fye (2013)
10.1007/s12094-013-1117-y
Peroxiredoxin 3 is resistant to oxidation-induced apoptosis of Hep-3b cells
Y-G Wang (2014)
10.1371/journal.pone.0039404
Peroxiredoxin 3 Is a Redox-Dependent Target of Thiostrepton in Malignant Mesothelioma Cells
Kheng Newick (2012)
10.1111/j.1349-7006.2012.02368.x
Comparative proteomic profiles indicating genetic factors may involve in hepatocellular carcinoma familial aggregation
Da-Ni Zhong (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar